Moores Cancer Center ( Site 0116) |
La Jolla, California, United States, 92093-0698 |
Contact: Study Coordinator 858-349-2651 |
The Angeles Clinic and Research Institute - West Los Angeles Office ( Site 0123) |
Los Angeles, California, United States, 90025 |
Contact: Study Coordinator 310-231-2153 |
UCLA Hematology/Oncology - Westwood (Building 100) ( Site 0131) |
Los Angeles, California, United States, 90095 |
Contact: Study Coordinator 310-794-6892 |
California Pacific Medical Center - Pacific Campus ( Site 0111) |
San Francisco, California, United States, 94115 |
Contact: Study Coordinator 415-885-8600 |
UCSF Medical Center at Mission Bay ( Site 0130) |
San Francisco, California, United States, 94158 |
Contact: Study Coordinator 415-353-7392 |
The Melanoma & Skin Cancer Institute ( Site 0120) |
Englewood, Colorado, United States, 80113 |
Contact: Study Coordinator 720-316-8091 |
Georgetown University Medical Center ( Site 0144) |
Washington, District of Columbia, United States, 20007 |
Contact: Study Coordinator 202-444-2198 |
University of Miami Hospital and Clinics, Sylvester Cancer Center ( Site 0110) |
Miami, Florida, United States, 33136 |
Contact: Study Coordinator 305-243-4981 |
Moffitt Cancer Center, Richard M. Shulze Family Foundation Outpatient Center ( Site 0124) |
Tampa, Florida, United States, 33612 |
Contact: Study Coordinator 813-745-8581 |
Northwestern Memorial Hospital ( Site 0109) |
Chicago, Illinois, United States, 60611 |
Contact: Study Coordinator 312-472-1234 |
Advocate Medical Group-Oncology ( Site 0102) |
Park Ridge, Illinois, United States, 60068 |
Contact: Study Coordinator 847268-8200 |
University of Iowa-Holden Comprehensive Cancer Center ( Site 0107) |
Iowa City, Iowa, United States, 52242 |
Contact: Study Coordinator 319-356-2324 |
Henry Ford Hospital ( Site 0133) |
Detroit, Michigan, United States, 48202 |
Contact: Study Coordinator 313-725-7636 |
Comprehensive Cancer Centers of Nevada ( Site 0142) |
Las Vegas, Nevada, United States, 89169 |
Contact: Study Coordinator 702-952-1242 |
R.J. Zuckerberg Cancer Center-Medical Oncology ( Site 0132) |
Lake Success, New York, United States, 11042 |
Contact: Study Coordinator 516-734-8866 |
Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0146) |
Mineola, New York, United States, 11501 |
Contact: Study Coordinator 212-731-5431 |
Laura and Isaac Perlmutter Cancer Center-Hematology and Oncology ( Site 0113) |
New York, New York, United States, 10016 |
Contact: Study Coordinator 212-731-5431 |
Icahn School of Medicine at Mount Sinai ( Site 0118) |
New York, New York, United States, 10029 |
Contact: Study Coordinator 212-824-7312 |
Weill Cornell Medical College ( Site 0115) |
New York, New York, United States, 10065 |
Contact: Study Coordinator 646-962-6444 |
Levine Cancer Institute ( Site 0138) |
Charlotte, North Carolina, United States, 28204 |
Contact: Study Coordinator 980-442-2000 |
Sanford Fargo Medical Center ( Site 0127) |
Fargo, North Dakota, United States, 58102 |
Contact: Study Coordinator 701-234-7551 |
Children's Hospital of Pittsburgh ( Site 0141) |
Pittsburgh, Pennsylvania, United States, 15224 |
Contact: Study Coordinator 412-623-4511 |
UPMC Hillman Cancer Center ( Site 0135) |
Pittsburgh, Pennsylvania, United States, 15232 |
Contact: Study Coordinator 412-623-4511 |
Sanford Cancer Center ( Site 0125) |
Sioux Falls, South Dakota, United States, 57104 |
Contact: Study Coordinator 605-328-8000 |
The West Clinic, PLLC dba West Cancer Center ( Site 0119) |
Germantown, Tennessee, United States, 38138 |
Contact: Study Coordinator 901-683-0055 |
St. Jude Children's Research Hospital ( Site 0106) |
Memphis, Tennessee, United States, 38105 |
Contact: Study Coordinator 866-278-5833 |
Vanderbilt University Medical Center ( Site 0139) |
Nashville, Tennessee, United States, 37232 |
Contact: Study Coordinator 615-936-3524 |
University of Texas MD Anderson Cancer Center ( Site 0145) |
Houston, Texas, United States, 77030 |
Contact: Study Coordinator 713-792-4185 |
Inova Schar Cancer Institute ( Site 0103) |
Fairfax, Virginia, United States, 22031 |
Contact: Study Coordinator 202-615-8535 |
University of Wisconsin Hospital and Clinics ( Site 0108) |
Madison, Wisconsin, United States, 53792 |
Contact: Study Coordinator 608-265-1700 |
Centro de Investigaciones Metabólicas (CINME)-Oncology ( Site 0204) |
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, C1027AAP |
Contact: Study Coordinator 5491156455799 |
Instituto Alexander Fleming-Alexander Fleming ( Site 0209) |
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, C1426ANZ |
Contact: Study Coordinator 54111531493950 |
Centro de Educación Médica e Investigaciones Clínicas (CEMIC) ( Site 0200) |
Buenos Aires, Caba, Argentina, C1431FWO |
Contact: Study Coordinator 5411529901002543 |
Instituto de Oncología de Rosario ( Site 0206) |
Rosario, Santa Fe, Argentina, S2000KZE |
Contact: Study Coordinator 54 9 341 5778394 |
Sanatorio Finochietto ( Site 0212) |
Buenos Aires, Argentina, C1187AAN |
Contact: Study Coordinator 5491158216233 |
Clinica Adventista Belgrano-Oncology ( Site 0211) |
Caba, Argentina, C1430EGF |
Contact: Study Coordinator 5491132682903 |
Blacktown Hospital-Blacktown Cancer and Haematology Centre - Medical Oncology ( Site 1464) |
Blacktown, New South Wales, Australia, 2148 |
Contact: Study Coordinator 61298455200 |
Calvary Mater Newcastle-Medical Oncology ( Site 1462) |
Waratah, New South Wales, Australia, 2298 |
Contact: Study Coordinator 61249211561 |
Melanoma Institute Australia-Clinical Trials Unit ( Site 1450) |
Wollstonecraft, New South Wales, Australia, 2065 |
Contact: Study Coordinator 61299117336 |
Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si |
Brisbane, Queensland, Australia, 4029 |
Contact: Study Coordinator 61736464311 |
Cairns Hospital-Clinical Research Unit ( Site 1458) |
Cairns, Queensland, Australia, 4870 |
Contact: Study Coordinator 61499200998 |
Gallipoli Medical Research Ltd-GMRF CTU ( Site 1451) |
Greenslopes, Queensland, Australia, 4120 |
Contact: Study Coordinator +61448632604 |
Tasman Oncology Research ( Site 1456) |
Southport, Queensland, Australia, 4215 |
Contact: Study Coordinator +61 7 5613 2480 |
Royal Adelaide Hospital-RAH Cancer Centre ( Site 1457) |
Adelaide, South Australia, Australia, 5000 |
Contact: Study Coordinator 61870745559 |
Icon Cancer Centre Hobart ( Site 1465) |
Hobart, Tasmania, Australia, 7000 |
Contact: Study Coordinator 61361668308 |
Peter MacCallum Cancer Centre-Parkville Cancer Clinical Trials Unit (PCCTU) ( Site 1455) |
Melbourne, Victoria, Australia, 3000 |
Contact: Study Coordinator +6138559500 |
One Clinical Research ( Site 1460) |
Nedlands, Western Australia, Australia, 6009 |
Contact: Study Coordinator 0410565868 |
Universitätsklinikum St. Pölten-Department of Dermatology ( Site 0606) |
St. Polten, Niederosterreich, Austria, 3100 |
Contact: Study Coordinator +43 2742 9004 11091 |
Ordensklinikum Linz GmbH Elisabethinen-Dermatologie ( Site 0602) |
Linz, Oberosterreich, Austria, 4020 |
Contact: Study Coordinator +4373276764508 |
Medizinische Universität Graz-Innere Medizin Klin. Abt. Onkologie ( Site 0601) |
Graz, Steiermark, Austria, 8036 |
Contact: Study Coordinator +4331638581320 |
Medizinische Universitaet Innsbruck-Univ Klinik für Dermatologie, Venerologie und Allergologie ( Sit |
Innsbruck, Tirol, Austria, 6020 |
Contact: Study Coordinator +4351250481473 |
Medizinische Universität Wien-Department of Dermatology ( Site 0600) |
Vienna, Wien, Austria, 1090 |
Contact: Study Coordinator +4314040077310 |
Uniklinikum Salzburg-Department of Dermatology and Allergology ( Site 0604) |
Salzburg, Austria, 5020 |
Contact: Study Coordinator +435725557842 |
GZA Ziekenhuizen campus Sint-Augustinus ( Site 0655) |
Wilrijk, Antwerpen, Belgium, 2610 |
Contact: Study Coordinator +3234433737 |
Cliniques universitaires Saint-Luc ( Site 0652) |
Brussels, Bruxelles-Capitale, Region De, Belgium, 1200 |
Contact: Study Coordinator 3227645471 |
Jessa Ziekenhuis ( Site 0656) |
Hasselt, Limburg, Belgium, 3500 |
Contact: Study Coordinator 0473 497 669 |
Université Catholique de Louvain-Namur - Centre Hospitalier -Oncology ( Site 0653) |
Yvoir, Namur, Belgium, 5530 |
Contact: Study Coordinator 3281423858 |
VITAZ-Medical Oncology ( Site 0654) |
Sint-Niklaas, Oost-Vlaanderen, Belgium, B-9100 |
Contact: Study Coordinator 3293326056 |
UZ Leuven-General Medical Oncology ( Site 0650) |
Leuven, Vlaams-Brabant, Belgium, 3000 |
Contact: Study Coordinator 3216346900 |
Centro Avançado de Tratamento Oncológico- CENANTRON ( Site 0256) |
Belo Horizonte, Minas Gerais, Brazil, 30130090 |
Contact: Study Coordinator 5531999785050 |
Hospital de Cancer de Londrina-Clinical Research Unit ( Site 0252) |
Londrina, Parana, Brazil, 86015-520 |
Contact: Study Coordinator +5543999087733 |
Associação Hospitalar Beneficente São Vicente de Paulo-Instituto do Câncer ( Site 0259) |
Passo Fundo, Rio Grande Do Sul, Brazil, 99010-080 |
Contact: Study Coordinator 555421033490 |
ANIMI - Unidade de Tratamento Oncologico ( Site 0255) |
Lages, Santa Catarina, Brazil, 88501001 |
Contact: Study Coordinator 4933805200 |
CEPHO - Centro de Estudos e Pesquisas de Hematologia e Oncologia ( Site 0262) |
Santo André, Sao Paulo, Brazil, 09060-870 |
Contact: Study Coordinator 5511974029832 |
A. C. Camargo Cancer Center ( Site 0258) |
Sao Paulo, Brazil, 01509-010 |
Contact: Study Coordinator +55 11 994270884 |
The Ottawa Hospital - General Campus-The Ottawa Hospital Cancer Centre ( Site 0004) |
Ottawa, Ontario, Canada, K1H 8L6 |
Contact: Study Coordinator 6137377700 ext 70208 |
Sunnybrook Research Institute ( Site 0003) |
Toronto, Ontario, Canada, M4N 3M5 |
Contact: Study Coordinator (416) 480-4270 |
Princess Margaret Cancer Centre ( Site 0006) |
Toronto, Ontario, Canada, M5G 2M9 |
Contact: Study Coordinator 4169464628 |
Oncocentro Valdivia ( Site 0307) |
Valdivia, Los Rios, Chile, 5112129 |
Contact: Study Coordinator +56992195434 |
FALP-UIDO ( Site 0303) |
Santiago, Region M. De Santiago, Chile, 7500921 |
Contact: Study Coordinator 56224457254 |
Oncovida ( Site 0304) |
Santiago, Region M. De Santiago, Chile, 7510032 |
Contact: Study Coordinator 56986303096 |
Clínica UC San Carlos de Apoquindo ( Site 0305) |
Santiago, Region M. De Santiago, Chile, 7620002 |
Contact: Study Coordinator 56223546919 |
Bradfordhill-Clinical Area ( Site 0302) |
Santiago, Region M. De Santiago, Chile, 8420383 |
Contact: Study Coordinator +56 9 84859580 |
ONCOCENTRO APYS-ACEREY ( Site 0300) |
Viña del Mar, Valparaiso, Chile, 2520598 |
Contact: Study Coordinator +56992369820 |
Bradford Hill Norte ( Site 0308) |
Antofagasta, Chile, 1240000 |
Contact: Study Coordinator 56994198125 |
Beijing Ji Shui Tan Hospital ( Site 1657) |
Beijing, Beijing, China, 100035 |
Contact: Study Coordinator 13801132522 |
Beijing Cancer hospital-Renal carcinoma and melanoma ( Site 1650) |
Beijing, Beijing, China, 100142 |
Contact: Study Coordinator 8613911233048 |
Chongqing University Cancer Hospital ( Site 1651) |
Chongqing, Chongqing, China, 400030 |
Contact: Study Coordinator +8615923245950 |
Fujian Provincial Cancer Hospital ( Site 1659) |
Fuzhou, Fujian, China, 350014 |
Contact: Study Coordinator 8613859089836 |
Sun Yat-sen University Cancer Center-melanoma ( Site 1655) |
Guangzhou, Guangdong, China, 510060 |
Contact: Study Coordinator 15915733209 |
Guangxi Medical University Affiliated Tumor Hospital ( Site 1668) |
Nanning, Guangxi, China, 530021 |
Contact: Study Coordinator 18677102309 |
Fourth Hospital of Hebei Medical University ( Site 1669) |
Shijiazhuang, Hebei, China, 050035 |
Contact: Study Coordinator +86 13831195070 |
The Third Hospital of Zhengzhou-Oncology ( Site 1653) |
Zhengzhou Shi, Henan, China, 450001 |
Contact: Study Coordinator 13937130192 |
Wuhan Union Hospital Cancer Center-Cancer Center ( Site 1664) |
Wuhan, Hubei, China, 430022 |
Contact: Study Coordinator 15807183251 |
The Second Xiangya Hospital of Central South University-Oncology ( Site 1673) |
Changsha, Hunan, China, 410011 |
Contact: Study Coordinator 13973130429 |
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Oncology ( |
NanJing, Jiangsu, China, 210000 |
Contact: Study Coordinator 8615951956162 |
Jiangsu Province Hospital-Oncology Department ( Site 1663) |
Nanjing, Jiangsu, China, 210029 |
Contact: Study Coordinator +8613951807457 |
The First Affiliated Hospital of Nanchang University ( Site 1652) |
Nanchang, Jiangxi, China, 330006 |
Contact: Study Coordinator 13870051522 |
The First Hospital of Jilin University-Oncology ( Site 1665) |
Changchun, Jilin, China, 130021 |
Contact: Study Coordinator 8613944888991 |
Fudan University Shanghai Cancer Center ( Site 1658) |
Shanghai, Shanghai, China, 200032 |
Contact: Study Coordinator 8613916860586 |
Shanxi Bethune Hospital ( Site 1660) |
Taiyuan, Shanxi, China, 030032 |
Contact: Study Coordinator 02783663425 |
West China Hospital, Sichuan University-Head and Neck Oncology ( Site 1667) |
Cheng Du, Sichuan, China, 610041 |
Contact: Study Coordinator +86 18980601130 |
Tianjin Medical University Cancer Institute & Hospital-Biotherapy ( Site 1671) |
Tianjin, Tianjin, China |
Contact: Study Coordinator 8618622221235 |
Xinjiang Medical University Cancer Hospital - Urumqi-Bone and Soft Tissue Department ( Site 1674) |
Urumqi, Xinjiang, China, 830000 |
Contact: Study Coordinator 13999153829 |
Yunnan Province Cancer Hospital-Biotherapy Center ( Site 1666) |
Kunming, Yunnan, China, 650106 |
Contact: Study Coordinator +8613888052830 |
Zhejiang Cancer Hospital-Oncology ( Site 1661) |
Hangzhou, Zhejiang, China, 310022 |
Contact: Study Coordinator 8613750851650 |
Instituto de Cancerología ( Site 0356) |
Medellin, Antioquia, Colombia, 050025 |
Contact: Study Coordinator 340 93 93 |
Fundación Colombiana de Cancerología Clínica Vida ( Site 0355) |
Medellin, Antioquia, Colombia, 050030 |
Contact: Study Coordinator 573126867004 |
Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia-Center Investigator ( Site 0358) |
Bogota, Distrito Capital De Bogota, Colombia, 111321 |
Contact: Study Coordinator 573103469453 |
Mediservis del Tolima IPS S.A.S ( Site 0357) |
Ibague, Tolima, Colombia, 730006 |
Contact: Study Coordinator +576082809432 |
Fundación Valle del Lili ( Site 0352) |
Cali, Valle Del Cauca, Colombia, 760032 |
Contact: Study Coordinator 573148883972 |
Centre Hospitalier de Valence-Service de Dermatologie ( Site 0702) |
Valence, Drome, France, 26953 |
Contact: Study Coordinator +33 475757549 |
Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu-Onco-Dermatology ( Site 0707) |
Nantes, Loire-Atlantique, France, 44093 |
Contact: Study Coordinator 02 40 08 31 44 |
Institut de Cancérologie de l'Ouest-Oncologie Médicale ( Site 0706) |
Saint Herblain, Loire-Atlantique, France, 44805 |
Contact: Study Coordinator 33240679900 |
Hopital Claude Huriez - CHU de Lille-Clinique de Dermatologie ( Site 0700) |
Lille, Nord-Pas-de-Calais, France, 59037 |
Contact: Study Coordinator 33320444193 |
Assistance Publique Hôpitaux de Marseille - Hôpital de la Ti-Service de Dermatologie et Cancérologi |
Marseille, Provence-Alpes-Cote-d Azur, France, 13005 |
Contact: Study Coordinator 33491387991 |
Centre Hospitalier de Pau ( Site 0708) |
Pau, Pyrenees-Atlantiques, France, 64000 |
Contact: Study Coordinator 33559924848 |
centre hospitalier lyon sud-Service de dermatologie ( Site 0714) |
Pierre-Bénite, Rhone, France, 69310 |
Contact: Study Coordinator 33478861679 |
Gustave Roussy-Dermatologie ( Site 0713) |
Villejuif, Val-de-Marne, France, 94800 |
Contact: Study Coordinator 33142114210 |
Hopitaux Universitaires Paris Centre-Hopital Cochin ( Site 0711) |
Paris, France, 75014 |
Contact: Study Coordinator +3358411765 |
Universitaetsklinikum Heidelberg ( Site 0765) |
Heidelberg, Baden-Wurttemberg, Germany, 69120 |
Contact: Study Coordinator +49 6221 56-36871 |
Universitätsmedizin Mannheim ( Site 0751) |
Mannheim, Baden-Wurttemberg, Germany, 68167 |
Contact: Study Coordinator 496213834461 |
Universitaetsklinikum Erlangen-Hautklinik ( Site 0750) |
Erlangen, Bayern, Germany, 91054 |
Contact: Study Coordinator 0049-9131-8545810 |
Klinik und Poliklinik für Dermatologie und Allergologie-Dermato-oncology ( Site 0757) |
München, Bayern, Germany, 80337 |
Contact: Study Coordinator +4989440056065 |
Elbe Kliniken Stade-Buxtehude, Klinikum Buxtehude-Dermatologisches Zentrum ( Site 0754) |
Buxtehude, Niedersachsen, Germany, 21614 |
Contact: Study Coordinator +49 (0)4161 703 6212 |
Medizinische Hochschule Hannover ( Site 0758) |
Hannover, Niedersachsen, Germany, 30625 |
Contact: Study Coordinator +49 (0) 511 532 7678 |
Universitaetsklinikum Essen-Klinik für Dermatologie, Venerologie und Allergologie ( Site 0761) |
Essen, Nordrhein-Westfalen, Germany, 45147 |
Contact: Study Coordinator 00492017232325 |
Johannes Wesling Klinikum Minden-Skin Cancer Center Minden ( Site 0759) |
Minden, Nordrhein-Westfalen, Germany, 32429 |
Contact: Study Coordinator 495717094501 |
Universitaetsklinikum Carl Gustav Carus Dresden-Klinik und Poliklinik für Dermatologie ( Site 0766) |
Dresden, Sachsen, Germany, 01307 |
Contact: Study Coordinator 4935145819782 |
Universitätsklinikum Leipzig ( Site 0762) |
Leipzig, Sachsen, Germany, 04103 |
Contact: Study Coordinator 00493419718600 |
Universitaetsklinikum Schleswig-Holstein Campus Kiel-Hautklinik ( Site 0767) |
Kiel, Schleswig-Holstein, Germany, 24105 |
Contact: Study Coordinator 4943150021130 |
Charité Universitaetsmedizin Berlin - Campus Mitte-Hauttumorcentrum Charité (HTCC) ( Site 0756) |
Berlin, Germany, 10117 |
Contact: Study Coordinator +4930450518002 |
Universitaetsklinikum Hamburg-Eppendorf ( Site 0752) |
Hamburg, Germany, 20246 |
Contact: Study Coordinator +49 (0)40 7410-53651 |
All India Institute of Medical Sciences-Medical oncology ( Site 1552) |
New Delhi, Delhi, India, 110029 |
Contact: Study Coordinator 919958975343 |
Artemis hospital ( Site 1551) |
Gurugram, Haryana, India, 122001 |
Contact: Study Coordinator 8377828241 |
Tata Memorial Hospital-Medical Oncology ( Site 1550) |
Mumbai, Maharashtra, India, 400012 |
Contact: Study Coordinator 919920640040 |
St. James's Hospital-Cancer clinical trials office ( Site 0900) |
Dublin, Ireland, D08 E9P6 |
Contact: Study Coordinator 35314144299 |
Beaumont Hospital, Dublin-Cancer Clinical Trials & Research Unit ( Site 0902) |
Dublin, Ireland, Dublin 9 |
Contact: Study Coordinator 01-8092010 |
Emek Medical Center-oncology ( Site 0952) |
Afula, Israel, 1834111 |
Contact: Study Coordinator 97246495723 |
Soroka Medical Center ( Site 0953) |
Be'er Sheva, Israel, 8410101 |
Contact: Study Coordinator 97286400797 |
Rambam Health Care Campus-Oncology Division ( Site 0955) |
Haifa, Israel, 3109601 |
Contact: Study Coordinator 04-777-6700 |
Hadassah Medical Center ( Site 0951) |
Jerusalem, Israel, 9112001 |
Contact: Study Coordinator 972505172537 |
Rabin Medical Center-Oncology ( Site 0954) |
Petah Tikva, Israel, 4941492 |
Contact: Study Coordinator +972-3-9378077 |
Sheba Medical Center-ONCOLOGY ( Site 0950) |
Ramat Gan, Israel, 5265601 |
Contact: Study Coordinator 97235302243 |
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori ( Site 1004) |
Meldola, Emilia-Romagna, Italy, 47014 |
Contact: Study Coordinator +390543739274 |
Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 1000) |
Milan, Lombardia, Italy, 20133 |
Contact: Study Coordinator 390223902557 |
Instituto Tumori Giovanni Paolo II ( Site 1003) |
Bari, Puglia, Italy, 70124 |
Contact: Study Coordinator +39 0805555138 |
A.O.U. Policlinico Paolo Giaccone-Depatment of Discipline Chirurgiche, Oncologiche e Stomatologiche |
Palermo, Sicilia, Italy, 90129 |
Contact: Study Coordinator 390916552507 |
Azienda Ospedaliero Universitaria Senese ( Site 1005) |
Siena, Toscana, Italy, 53100 |
Contact: Study Coordinator 390577586335 |
AO Santa Maria della Misericordia ( Site 1006) |
Perugia, Umbria, Italy, 06129 |
Contact: Study Coordinator 00393386605619 |
Istituto Europeo di Oncologia IRCCS ( Site 1008) |
Milano, Italy, 20141 |
Contact: Study Coordinator +390294372754 |
Azienda Ospedaliero Universitaria ( Site 1002) |
Modena, Italy, 41125 |
Contact: Study Coordinator +39 059 422 3200 |
Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 1001) |
Napoli, Italy, 80131 |
Contact: Study Coordinator +3908159031886S |
Nagoya University Hospital ( Site 1753) |
Nagoya-Shi, Aichi, Japan, 466-8560 |
Sapporo Medical University Hospital ( Site 1755) |
Sapporo, Hokkaido, Japan, 060-8543 |
Contact: Study Coordinator +81-11-611-2111 |
Niigata Cancer Center Hospital ( Site 1751) |
Niigata-shi, Niigata, Japan, 951-8566 |
Shizuoka Cancer Center ( Site 1752) |
Nagaizumi-cho,Sunto-gun, Shizuoka, Japan, 411-8777 |
National Cancer Center Hospital ( Site 1750) |
Chuo-ku, Tokyo, Japan, 104-0045 |
Contact: Study Coordinator +81-3-3542-2511 |
Osaka International Cancer Institute ( Site 1754) |
Osaka, Japan, 541-8567 |
Seoul National University Hospital-Oncology ( Site 1600) |
Seoul, Korea, Republic of, 03080 |
Contact: Study Coordinator 82220724035 |
Severance Hospital, Yonsei University Health System-Medical oncology ( Site 1601) |
Seoul, Korea, Republic of, 03722 |
Contact: Study Coordinator 82222288138 |
Samsung Medical Center-Division of Hematology/Oncology ( Site 1602) |
Seoul, Korea, Republic of, 06351 |
Contact: Study Coordinator +82-2-3410-6820 |
Tauranga Hospital-Bay of Plenty Clinical Trials Unit ( Site 1501) |
Tauranga, Bay Of Plenty, New Zealand, 3112 |
Contact: Study Coordinator 0278004008 |
New Zealand Clinical Research (Christchurch) ( Site 1509) |
Christchurch, Canterbury, New Zealand, 8011 |
Contact: Study Coordinator 6433640020 |
P3 Research - Palmerston North ( Site 1510) |
Palmerston North, Manawatu-Wanganui, New Zealand, 4414 |
Contact: Study Coordinator 6463508130 |
Dunedin Hospital ( Site 1511) |
Dunedin, Otago, New Zealand, 9016 |
Contact: Study Coordinator 6437470999 |
Harbour Cancer & Wellness ( Site 1508) |
Auckland, New Zealand, 0627 |
Contact: Study Coordinator 6421783590 |
Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 1061) |
Bydgoszcz, Kujawsko-pomorskie, Poland, 85-796 |
Contact: Study Coordinator 0048523743029 |
Pratia MCM Krakow ( Site 1053) |
Krakow, Malopolskie, Poland, 30-727 |
Contact: Study Coordinator +48607941715 |
Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 1058) |
Siedlce, Mazowieckie, Poland, 08-110 |
Contact: Study Coordinator +48256403493 |
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie ( |
Warszawa, Mazowieckie, Poland, 02-781 |
Contact: Study Coordinator +48226439375 |
Bialostockie Centrum Onkologii ( Site 1065) |
Bialystok, Podlaskie, Poland, 15-027 |
Contact: Study Coordinator +48856646888 |
Uniwersyteckie Centrum Kliniczne-Klinika Chirurgii Onkologicznej, Transplantacyjnej i Ogólnej ( Site |
Gdańsk, Pomorskie, Poland, 80-214 |
Contact: Study Coordinator 0048585846280 |
Wojewódzki Szpital Specjalistyczny im. J. Korczaka w Słupsku-Oncologii, Chemioterapii ( Site 1064) |
Słupsk, Pomorskie, Poland, 76-200 |
Contact: Study Coordinator +48604975136 |
Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 1056) |
Gliwice, Slaskie, Poland, 44-101 |
Contact: Study Coordinator 48784981888 |
Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zaklad Opieki Zdrowotnej ( Site 1054) |
Kielce, Swietokrzyskie, Poland, 25-734 |
Contact: Study Coordinator +48413674315 |
Szpital Kliniczny im. H. Swiecickiego nr 2-Oddział Kliniczny Onkologii Klinicznej i Doświadczalnej ( |
Poznan, Wielkopolskie, Poland, 60-780 |
Contact: Study Coordinator 48606228277 |
Zachodniopomorskie Centrum Onkologii ( Site 1063) |
Szczecin, Zachodniopomorskie, Poland, 71-730 |
Contact: Study Coordinator +48914251410 |
CANCERCARE LANGENHOVEN DRIVE ONCOLOGY CENTRE ( Site 1161) |
Port Elizabeth, Eastern Cape, South Africa, 6055 |
Contact: Study Coordinator 27413630581 |
Medical Oncology Centre of Rosebank ( Site 1160) |
Johannesburg, Gauteng, South Africa, 2196 |
Contact: Study Coordinator 0824445473 |
Wilgers Oncology Centre ( Site 1154) |
Pretoria, Gauteng, South Africa, 0040 |
Contact: Study Coordinator +27128072744 |
Curo Oncology ( Site 1158) |
Pretoria, Gauteng, South Africa, 0084 |
Contact: Study Coordinator +27 82 822 5556 |
LIFE GROENKLOOF-Mary Potter Cancer Centre ( Site 1152) |
Pretoria, Gauteng, South Africa, 0181 |
Contact: Study Coordinator 27123466701 |
Sandton Oncology Medical Group (Pty) Ltd-Research ( Site 1151) |
Sandton, Gauteng, South Africa, 2196 |
Contact: Study Coordinator 27118830900 |
The Oncology Centre ( Site 1157) |
Durban, Kwazulu-Natal, South Africa, 4091 |
Contact: Study Coordinator 27312099030 |
Abraham Oncology ( Site 1150) |
Richards Bay, Kwazulu-Natal, South Africa, 3900 |
Contact: Study Coordinator 0845493493 |
Cape Town Oncology Trials ( Site 1155) |
Cape Town, Western Cape, South Africa, 7570 |
Contact: Study Coordinator 27219443832 |
Cancercare Rondebosch Oncology-Clinical trials ( Site 1159) |
Rondebosch, Western Cape, South Africa, 7700 |
Contact: Study Coordinator 27219443700 |
Institut Català d'Oncologia - L'Hospitalet ( Site 1202) |
L'Hospitalet de Llobregat, Barcelona, Spain, 08908 |
Contact: Study Coordinator 34932607333 |
Onkologikoa - Instituto Oncologico de San Sebastian ( Site 1203) |
Doniostia - San Sebastian, Gipuzkoa, Spain, 20014 |
Contact: Study Coordinator 34943328315 |
Hospital Universitario Ramón y Cajal-Medical Oncology ( Site 1204) |
Madrid, Madrid, Comunidad De, Spain, 28034 |
Contact: Study Coordinator (+34) 913368263 |
H.R.U Málaga - Hospital General-Oncology ( Site 1201) |
Málaga, Malaga, Spain, 29011 |
Contact: Study Coordinator 34951291425 |
Hospital General Universitario de Valencia ( Site 1200) |
Valencia, Valenciana, Comunitat, Spain, 46014 |
Contact: Study Coordinator 34963131800437635 |
Hospital Universitario Virgen Macarena-Unidad de Investigación Oncológica ( Site 1205) |
Sevilla, Spain, 41009 |
Contact: Study Coordinator 34600162731 |
Länssjukhuset Ryhov-Onkologkliniken ( Site 1253) |
Jönköping, Jonkopings Lan, Sweden, 553 05 |
Contact: Study Coordinator 46102429483 |
Karolinska Universitetssjukhuset Solna ( Site 1252) |
Stockholm, Stockholms Lan, Sweden, 171 64 |
Contact: Study Coordinator 46851770000 |
University Hospital Basel ( Site 1303) |
Basel, Basel-Stadt, Switzerland, 4056 |
Contact: Study Coordinator +41 61 32 8 60 16 |
Inselspital Bern ( Site 1301) |
Bern, Berne, Switzerland, 3010 |
Contact: Study Coordinator 031 632 41 14 |
Hôpitaux Universitaires de Genève (HUG)-Oncology ( Site 1307) |
Genève, Geneve, Switzerland, 1211 |
Contact: Study Coordinator 0041223729862 |
Ospedale Regionale Bellinzona e Valli ( Site 1308) |
Bellinzona, Ticino, Switzerland, 6500 |
Contact: Study Coordinator 00418119411 |
CHUV (centre hospitalier universitaire vaudois) ( Site 1304) |
Lausanne, Vaud, Switzerland, 1011 |
Contact: Study Coordinator 41795562698 |
Hôpital de Sion ( Site 1305) |
Sion, Wallis, Switzerland, 1951 |
Contact: Study Coordinator 41795567881 |
UniversitätsSpital Zürich-Dermatology ( Site 1300) |
Zürich Flughafen, Zurich, Switzerland, 8058 |
Contact: Study Coordinator 41442552588 |
Cantonal Hospital St.Gallen-Oncology & Hematology ( Site 1306) |
Sankt Gallen, Switzerland, 9007 |
Contact: Study Coordinator 41714941111 |
Ankara City Hospital-Medical Oncology ( Site 1357) |
Cankaya, Ankara, Turkey, 06800 |
Contact: Study Coordinator 905052933234 |
I.E.U. Medical Point Hastanesi-Oncology ( Site 1360) |
Izmir, Karsiyaka, Izmir, Turkey, 009035575 |
Contact: Study Coordinator +905052642353 |
Hacettepe Universite Hastaneleri ( Site 1363) |
Ankara, Turkey, 06230 |
Contact: Study Coordinator 905326880089 |
Liv Hospital Ankara-Oncology ( Site 1353) |
Ankara, Turkey, 06680 |
Contact: Study Coordinator 905056604536 |
Akdeniz Universitesi Hastanesi-Medical Oncology ( Site 1355) |
Antalya, Turkey, 07059 |
Contact: Study Coordinator 905052312377 |
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 1358) |
Istanbul, Turkey, 34722 |
Contact: Study Coordinator 00905063509061 |
Mersin Sehir Eğitim ve Araştırma Hastanesi-Oncology ( Site 1361) |
Mersin, Turkey, 33240 |
Contact: Study Coordinator +9005458259095 |
Ondokuz Mayıs Universitesi-Oncology department ( Site 1359) |
Samsun, Turkey, 55139 |
Contact: Study Coordinator +90 53 25992825 |
Addenbrooke's Hospital ( Site 1400) |
Cambridge, Cambridgeshire, United Kingdom, CB2 2QQ |
Contact: Study Coordinator 441223274401 |
University College London Hospital ( Site 1405) |
London, England, United Kingdom, NW1 2PG |
Contact: Study Coordinator 4402034475085 |
Guy's & St Thomas' NHS Foundation Trust-Oncology & Haematology Clinical Trials ( Site 1401) |
London, London, City Of, United Kingdom, SE1 9RT |
Contact: Study Coordinator 44 020 7188 3386 |